NABRIVA THERAPEUTICS PLC |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0001 USD | -.--% |
|
-.--% | +9,900.00% |
| 2023 | Nabriva Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 | CI |
| 2023 | Nabriva Therapeutics plc(OTCPK:NBRV.F) dropped from NASDAQ Composite Index | CI |
Quotes 5-day view
Delayed Quote OTC Markets| 2024-04-25 | |
|---|---|
| Last | 0.0001 $ |
| Volume | 1 358 |
| Change | +∞% |
| Opening | 0.00 |
| High | 0.00 |
| Low | 0.00 |
Performance
| 6 months | -99.98% | ||
| 1 year | -99.99% | ||
| 3 years | -100.00% | ||
| 5 years | -100.00% |
Volumes
marketsDaily volume
1 358
Estimated daily volume
1 706
Avg. Volume 20 sessions
1 361
Daily volume ratio
1.25
Avg. Volume 20 sessions USD
0.14
Record volume 1
5 619 564
Record volume 2
4 150 216
Record volume 3
2 476 893
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
323
Net sales (USD)
36 935 000
Number of employees
39
Sales / Employee (USD)
947 051
Free-Float
99.05 %
Free-Float capitalization (USD)
320
Average Daily Capital Traded
0.04%
Highs and lows
1 week
0.00
0.00
1 month
0.000.00
Current year
0.000.52
1 year
0.002.24
3 years
0.0058.00
5 years
0.00702.25
10 years
0.004 370.00
Indicators
Moving average 20 days
0.03
Moving average 50 days
0.01
Moving average 100 days
0.02
Price spread / (MMA20)
+26,200.00%
Price spread / (MMA50)
+10,500.00%
Price spread / (MMA100)
+15,900.00%
RSI 9 days
46.92
RSI 14 days
47.33
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | -99.99% | 323 | ||
| -0.24% | +0.81% | -1.47% | +15.86% | 104B | ||
| +3.86% | +5.25% | +6.73% | +17.41% | 97.47B | ||
| +3.51% | +3.98% | +5.71% | +0.78% | 22.25B | ||
| +2.42% | +6.12% | -12.82% | -17.15% | 21.68B | ||
| -0.99% | -3.09% | -9.70% | -30.35% | 18.2B | ||
| -2.02% | +3.73% | -39.98% | -35.33% | 17.02B | ||
| +3.55% | +9.55% | -9.76% | -38.22% | 16.36B | ||
| -0.72% | +2.97% | +7.66% | +37.12% | 14.39B | ||
| +1.09% | +3.10% | +36.20% | +6.18% | 12.37B | ||
| -1.09% | +9.48% | +305.10% | +259.00% | 8.43B | ||
| +0.17% | +2.83% | +11.79% | +63.74% | 8.06B | ||
| +4.07% | +3.05% | -23.92% | -30.26% | 8B | ||
| +0.09% | +1.46% | +0.67% | +38.16% | 7.74B | ||
| +5.97% | +12.17% | -50.81% | -68.69% | 7.31B | ||
| +1.55% | +7.64% | +2.95% | +37.44% | 6.93B | ||
| Average | +1.33% | +3.10% | +15.22% | +9.73% | ||
| Weighted average by Cap. | +1.55% | +1.57% | +5.47% | +11.70% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +9,900.00% | ||
| 2023 | -100.00% | ||
| 2022 | -87.38% | ||
| 2021 | -75.25% | ||
| 2020 | -81.67% | ||
| 2019 | -9.59% | ||
| 2018 | -75.59% | ||
| 2017 | +0.34% | ||
| 2016 | -38.05% | ||
| 2015 | -27.34% |
- Stock Market
- Equities
- NBRVF Stock
- Quotes Nabriva Therapeutics plc
